Spots Global Cancer Trial Database for urinary bladder
Every month we try and update this database with for urinary bladder cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer | NCT00918008 | Bladder Cancer | Blood draw | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium | NCT00805129 | Bladder Cancer Metastatic Tran... | Everolimus | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma | NCT00714948 | Bladder Cancer URINARY BLADDER | gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium | NCT01551030 | Metastatic Tran... | Buparlisib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma | NCT00588666 | Myeloproliferat... Urothelial Carc... Cancer | Bevacizumab Carboplatin Gemcitabine | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma | NCT00714948 | Bladder Cancer URINARY BLADDER | gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium | NCT00805129 | Bladder Cancer Metastatic Tran... | Everolimus | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer | NCT03081858 | Bladder Cancer ... Non-Muscle Inva... Bladder Cancer Urinary Bladder Transitional Ce... Urinary Bladder... Urologic Neopla... Urogenital Neop... Urinary Bladder... Urologic Diseas... | TSD-001 | 18 Years - 85 Years | Lipac Oncology LLC | |
| Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer | NCT00847015 | Bladder Cancer Urinary Bladder | Sunitinib Gemcitabine cisplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Markers of Response to Intravesical Bladder Cancer Therapy | NCT01007058 | Bladder Cancer | 18 Years - | M.D. Anderson Cancer Center | ||
| Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer | NCT04496219 | Bladder Urothel... Recurrent Bladd... Stage 0a Bladde... Stage 0is Bladd... Stage I Bladder... Superficial Bla... | Acupuncture The... BCG Solution Best Practice Quality-of-Life... Questionnaire A... | 18 Years - | Fred Hutchinson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
